title: [Highly effective preoperative intraarterial infusion chemotherapy with CDDP for progressive uterine corpus cancer with a Sister Mary Joseph's nodule].
abstract: A 57-year-old female patient complained of atypical genital bleeding and a noxious emanation from her navel. A histological examination of the uterine body and the navel area confirmed a diagnosis of adenocarcinoma. We diagnosed it as IVb stage of uterine corpus cancer with a Sister Mary Joseph's nodule. We selectively administered intraarterial injection chemotherapy (Cisplatin 120 mg, Pirarubicin 40 mg) in the uterus and navel area (three times, once every three weeks) prior to surgery. The isolated uterus showed that the cancerous tissue had been eradicated, and we judged the cancer to be grade 3 following histopathological effective grading standards. The metastasis exhibited extreme shrinkage, but affirmed changes in the tumor quality. Currently, the patient is receiving maintenance therapy of 600 mg of Hysron H, and 600 mg of UFT. There are no indications of recurrence, and the patient is progressing well.
authors.affiliation: Dept. of Obstetrics and Gynecology, Kishiwada City Hospital, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Shirai
authors.forename: I
authors.initials: I
authors.lastname: Tateyama
authors.forename: T
authors.initials: T
authors.lastname: Kanamori
authors.forename: E
authors.initials: E
authors.lastname: Kadota
authors.forename: I
authors.initials: I
authors.lastname: Fujisawa
authors.forename: N
authors.initials: N
authors.lastname: Araki
authors.forename: K
authors.initials: K
authors.lastname: Harima
authors.forename: K
authors.initials: K
authors.lastname: Hashii
authors.forename: T
authors.initials: T
authors.lastname: Mori
mesh_terms: D000008:Abdominal Neoplasms / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D008875:Middle Aged; D012074:Remission Induction; D014472:Umbilicus; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D004317:Doxorubicin; C027260:pirarubicin; D002945:Cisplatin